VINCENT JAMES L

Director at ALNYLAM PHARMACEUTICALS, INC. · on record since Jun 2, 2006

Insider trading activity of VINCENT JAMES L

Transactions on record: 15; since Jul 13, 2005

Open-market buys: 0

Open-market sells: 4; $816.1K

Companies traded: 1; last filing Jun 18, 2010

Figures computed from official regulatory filings — .

Companies where VINCENT JAMES L has traded

ALNYLAM PHARMACEUTICALS, INC.15 tx · $1.2M · Jun 18, 2010

Track record of VINCENT JAMES L

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of VINCENT JAMES L

Co-insiders of VINCENT JAMES L

Abingworth Management LTDALNYLAM PHARMACEUTICALS, INC.
Allen Patricia LALNYLAM PHARMACEUTICALS, INC.
Arbuckle Stuart AALNYLAM PHARMACEUTICALS, INC.
ARCH V ENTREPRENEURS FUND LPALNYLAM PHARMACEUTICALS, INC.
ARCH VENTURE FUND V LPALNYLAM PHARMACEUTICALS, INC.
ARCH VENTURE PARTNERS V LLCALNYLAM PHARMACEUTICALS, INC.
ARCH VENTURE PARTNERS V LPALNYLAM PHARMACEUTICALS, INC.
Arnold Stephen DALNYLAM PHARMACEUTICALS, INC.
Atlas Venture Associates VI, L.P.ALNYLAM PHARMACEUTICALS, INC.
ATLAS VENTURE ASSOCIATES V LPALNYLAM PHARMACEUTICALS, INC.
ATLAS VENTURE ENTREPRENEURS FUND VI LPALNYLAM PHARMACEUTICALS, INC.
ATLAS VENTURE ENTREPRENEURS FUND V LPALNYLAM PHARMACEUTICALS, INC.
Atlas Venture Fund VI GmbH & Co KGALNYLAM PHARMACEUTICALS, INC.
ATLAS VENTURE FUND VI LPALNYLAM PHARMACEUTICALS, INC.
ATLAS VENTURE FUND V LPALNYLAM PHARMACEUTICALS, INC.
ATLAS VENTURE PARALLEL FUND V-A C VALNYLAM PHARMACEUTICALS, INC.
ATLAS VENTURE PARALLEL FUND V-B C VALNYLAM PHARMACEUTICALS, INC.
Ausiello Dennis AALNYLAM PHARMACEUTICALS, INC.
Barrett PeterALNYLAM PHARMACEUTICALS, INC.
Berriman John EALNYLAM PHARMACEUTICALS, INC.
Bertozzi Carolyn RALNYLAM PHARMACEUTICALS, INC.
BONNEY MICHAEL WALNYLAM PHARMACEUTICALS, INC.
BRANDICOURT OLIVIERALNYLAM PHARMACEUTICALS, INC.
BYBEE CLINTONALNYLAM PHARMACEUTICALS, INC.
CHP II LPALNYLAM PHARMACEUTICALS, INC.
CLARKE JOHN KALNYLAM PHARMACEUTICALS, INC.
CRANDELL KEITHALNYLAM PHARMACEUTICALS, INC.
Cravatt BenjaminALNYLAM PHARMACEUTICALS, INC.
DZAU VICTOR JALNYLAM PHARMACEUTICALS, INC.
Fanucci MarshaALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin JosephALNYLAM PHARMACEUTICALS, INC.
Flint Jonathan AALNYLAM PHARMACEUTICALS, INC.
Franchini Indrani LallALNYLAM PHARMACEUTICALS, INC.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
ALNYLAM PHARMACEUTICALS, INC.	Jun 18, 2010	ExerciseD (derivative)	-12,100	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 18, 2010	Sell	-8,667	15.16	$131.4K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 18, 2010	Exercise	12,100	7.02	$84.9K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 18, 2010	Sell	-1,333	15.70	$20.9K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 18, 2010	Sell	-12,100	15.19	$183.8K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 17, 2010	ExerciseD (derivative)	-30,000	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 17, 2010	Exercise	30,000	7.02	$210.6K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 17, 2010	Sell	-30,000	16.00	$480K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 4, 2010	AwardD (derivative)	15,000	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 12, 2009	AwardD (derivative)	15,000	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 5, 2008	AwardD (derivative)	15,000	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 5, 2007	AwardD (derivative)	15,000	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 2, 2006	AwardD (derivative)	10,000	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jul 13, 2005	Award	10,000	7.02 USD	$70.2K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jul 13, 2005	AwardD (derivative)	75,000	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
ALNYLAM PHARMACEUTICALS, INC.	Jun 18, 2010	ExerciseD (derivative)	-12,100	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 18, 2010	Sell	-8,667	15.16	$131.4K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 18, 2010	Exercise	12,100	7.02	$84.9K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 18, 2010	Sell	-1,333	15.70	$20.9K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 18, 2010	Sell	-12,100	15.19	$183.8K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 17, 2010	ExerciseD (derivative)	-30,000	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 17, 2010	Exercise	30,000	7.02	$210.6K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 17, 2010	Sell	-30,000	16.00	$480K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 4, 2010	AwardD (derivative)	15,000	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 12, 2009	AwardD (derivative)	15,000	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 5, 2008	AwardD (derivative)	15,000	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 5, 2007	AwardD (derivative)	15,000	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jun 2, 2006	AwardD (derivative)	10,000	0.00	—	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jul 13, 2005	Award	10,000	7.02 USD	$70.2K	SEC
ALNYLAM PHARMACEUTICALS, INC.	Jul 13, 2005	AwardD (derivative)	75,000	0.00 USD	—	SEC